Related Experiment Video
Updated: May 3, 2026

Novel Triple-Loop Technique for Suturing TFCC Injuries without Transosseous Tunnel
Published on: May 23, 2025
Characterization of Drug Resistance Patterns, Mutation Profiles and Prevalence of Mycobacterium tuberculosis in
Jinyun Zhao1, Weifang Mao1, Faxiang Jin1
1Department of Clinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, 312000, People's Republic of China.
Objective:
This study aimed to analyze drug resistance patterns, mutation profiles in Mycobacterium tuberculosis isolates and clinical characteristics of tuberculosis patients in Shaoxing, Zhejiang, China.
Methods:
Clinical specimens and data from tuberculosis patients admitted in 2024 were collected. Cultures were established using the MGIT liquid culture system, and drug susceptibility to twelve anti-tuberculosis agents (four first-line and eight second-line) was assessed by the microbroth dilution method. Mutations in the rpoB gene, katG gene, and inhA promoter were identified using a DNA microarray chip assay.
Results:
Among 268 Mycobacterium tuberculosis isolates, 62 (23.1%) exhibited resistance to at least one anti-tuberculosis drug. These comprised 21 (7.8%) mono-resistant, 25 (9.3%) poly-resistant, and 16 (6.0%) multidrug-resistant strains, including 3 (1.1%) classified as pre-extensively drug-resistant and 1 (0.4%) as extensively drug-resistant. Among rifampicin-resistant isolates, mutations at codons 531 (47.4%) and 526 (21.1%) of the rpoB gene were most frequent, while the katG Ser315Thr substitution was detected in 44.8% of isoniazid-resistant strains. Compared with primary cases, re-treated patients were more frequently over 50 years of age, exhibited a higher prevalence of pulmonary cavities, and showed significantly elevated rates of drug resistance (P < 0.05).
Conclusion:
Our findings indicate that although the overall prevalence of drug-resistant tuberculosis in Shaoxing remains low, the resistance patterns are heterogeneous. These results underscore the need for comprehensive drug susceptibility and genetic testing to guide effective treatment strategies.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
